Mr. Izumi Kamijo

MSc in Biophysics and Philosophy of science. Development of x-ray systems for protein structure analysis. Development of pH-sensitive cancer therapy under Prof. W. Kreutz, Univ. of Freiburg, Germany. CEO of Diflumed Pharmaceutical. Consulting clinics in Europe in the cancer therapy and related fields.